Discover how Professor Shabir Madhi is advancing maternal vaccines to safeguard newborns from RSV, GBS, and more.

A group of mothers in Victoria say they've experienced trouble accessing the jab for a highly infectious illness that infects ...

It is a mistake to claim that there is not widespread research into the effectiveness of vaccines, especially those given to ...

Medical staff in Western Australia have been warned after reports of the wrong immunisations being given to patients.

Merck & Co., Inc. (NYSE: MRK) is one of the. The company announced that the US FDA approved ENFLONSIA™ (clesrovimab-cfor) for ...

The WA Department of Health has sent an urgent reminder to medical staff to make sure they’re giving patients the right RSV ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...

The ACIP is recommending the use of Enflonsia for the prevention of RSV lower respiratory tract disease in infants younger than 8 months.

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

Colds and flu often cause sore throats that make swallowing and talking uncomfortable, while RSV in adults and older children usually mimics a mild cold. Cepacol® explores why sore throats are more ...

While respiratory syncytial virus (RSV) typically causes mild symptoms in adults, the virus can be life-threatening for infants. The seasonal virus is the most common cause of lower respiratory tract ...

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...